A better way to feed the planet

A better way to feed the planet

• 1.
  A thriving biotech contributingto A better way to feed the planet
• 2.
  A PLANET HUNGRYFOR FOOD AND PERFORMANCE The world needs more food People want better food Healthy Safe Responsible Experts say that we must double the food supply by 2050 in order to feed humanity. However, the planet cannot support doubling the land allocated to crops and animal grazing. There just aren’t enough resources. The solution is to improve the production process: increase yields, reduce waste, improve efficiency, find new and better food sources, and increase the nutritional value of existing ones. This is what Prevtec is out to do. You cannot have missed the growing appetite for healthier food. While consumers in developed countries call for less fat, less sugar, less salt, less additives of all sorts, poorer countries strive for a more balanced and nourishing diet. And as they get richer, they consume more meat, pushing the global meat demand to new heights. Prevtec’s focus is to help produce more high quality meat. Food scandals have ruined more than one appetite in recent years. When the culprit is not the omnipresent E. coli causing serious health issues, it is the remedies themselves, starting with the overuse of antibiotics. Prevtec helps improve food safety by fighting diseases with safe alternatives to drugs. Food production in general, and meat production especially, are often criticized for using huge amount of resources and producing vast amounts of waste that further burden the environment. By improving the efficiency of the production process, we consume fewer resources and generate less waste, and at the same time supply more food. This is exactly what Prevtec is working on. Source : Jeff Simmons, Elanco
• 3.
  Producers strive forperformance The industry requires innovation Productivity Efficiency Profitability The challenge to feed humanity fuels innovation and investment at all levels of the food industry. Fundamental changes are in store and some of them are driven from outside the industry itself: consumer activism and government regulation being only two examples of external forces at work. The animal health industry has risen to the challenge and is starting to adapt its practices and its products to the new market. Recently, major pharmas have launched massive outsourcing programs to find new alternatives to their traditional drugs, and especially the controversial antibiotics. Prevtec prides itself on offering effective medicines that are the best alternatives to antibiotics. The most obvious way to produce more abundant and more affordable food is to improve productivity. In animal farming, this means diminishing mortality rate, sickness prevalence and severity, increasing feed conversion and enhancing growth. If this reads like a list of Prevtec’s products benefits, that’s no accident. Producers are making every effort to improve the efficiency of their operations. Competition and rationalization favour optimal use of human and physical resources, streamlined procedures and protocols, and rapid turnover. Prevtec contributes to such improvements, for example with solutions that reduce animal handling, contribute to more uniform growth, and help diagnose problems early. Competition, consumer demand and government regulation are forcing the industry to change, requiring heavy investments. Producers are under a lot of pressure to balance cost increases with productivity gains in order to maintain profitability. Prevtec targets technologies that offer such advantages and markets products that are economically cost-effective. 75% 2020 Drugs Biologics 2010 25% 67% 33%
• 4.
  PREVTEC: A GLOBAL ANIMALHEALTH BIOTECH Innovative technologies Branded products High-value Biologics Timely Prevtec has pulled off a somewhat unique feat in the industry. We know of no other biotech that has achieved our global positioning and still maintains the level of control we have on the marketing and distribution of our products. Prevtec’s first product, Coliprotec®, is now marketed on two continents. We have international agreements for the sale of several of our products in Europe, Asia and Russia. Two of the largest animal health companies in the world are selling our products under Prevtec’s own name in a co-branding agreement. Furthermore, in every country where our products are approved, we have the exclusive ownership and control of the marketing authorization. Prevtec’s technologies offer solutions that have significant economic impacts on animal farming. Our vaccines target diseases that are costly to producers, such as post-weaning diarrhea, edema disease or streptococcus suis in pig production, avian colibacillosis and salmonellosis. Our portfolio includes such things as antibodies against hamburger disease in bovine. We develop feed additives that boost productivity in responsible, healthy and sustainable approaches. We don’t do antibiotics. More importantly, we offer a way for producer to efficiently reduce their use. It is always good practice to limit the use of antibiotics, and in a growing number of countries antibiotics are now being banned if used only as prevention measures or as growth promoters. Many of our technologies are cost-effective alternatives to antibiotics used as medication or growth factor. Our technologies are unique and they address painful problems in food production. No wonder large animal health companies are so interested in our offering. Our business model calls for a constant quest for high- interest, high-value opportunities that we can then leverage profitably to innovation-hungry organizations looking to fill their product portfolio.
• 5.
  International standing High-value expertise Prevtec’ssuccess rests upon a very special mix of three fields of expertise and three business attitudes. We blend veterinary, regulatory and management expertise with entrepreneurship, partnering and innovation. This unique combination has allowed Prevtec’s team to build a far-reaching presence in the global market in only a few years. Constantly acquiring new talents as we grow, we have achieved industry recognition for our ability to foster R&D, transfer technology to industry and license products worldwide. Prevtec has offices on 4 continents, either directly or through subsidiaries and representative offices. Our Coliprotec® vaccine is now sold in Canada and Brazil, while regulatory approval has been granted or filed for in 5 other jurisdictions, including Europe’s 23 countries. Our technical documentation is available in English, French, Portuguese, Russian and Chinese. We have patents recognised or pending in 10 countries and our trademarks are registered in 15 countries. Throughout the world, Prevtec has developed a network of partners and resources of great value. We have direct access to C-suite executives of the largest animal health organizations on the planet, world-class research organizations (CRO) and manufacturing facilities (CMO). We and our staff belong to global networks of researchers, scientists and academics.
• 6.
  Business model Our businessmodel is based on a unique mix of innovation and partnership strategies, implemented throughout the product development and marketing stages. We partner with scientists, academics and research organizations to discover and assess new technologies. We partner with universities and government agencies to further and finance research and development. Once our technologies achieve the proof of concept, we partner with contract research organizations (CROs) and contract manufacturing organizations (CMOs) to transform the technology into a winning commercial product. Finally, worldwide distribution is also achieved through international partnerships with animal health companies that are chosen for their strength in the various regional markets we target. However, Prevtec always keeps the lead over the development process, from scientific development to business development. We especially pride ourselves on maintaining ownership of the intellectual property related to our technologies and control of the regulatory certifications related to our products (also called marketing authorizations or licenses in various countries). Scouting for news technologies Research by researcher Research by CRO Sale by distributor Regulatory process Authorization Strategic assets Track record Technologies People Prevtec has a proven ability in transforming technologies into products, all the way from the lab to the global market. We have done what many industry veterans thought could not be done and we will soon hold the market authorization for our products in more than 12 countries over 4 continents. We have a deep knowledge of farming issues, animal health problems, and their potential solutions. By constantly scouting for promising technologies through our international network and often acting faster than the big pharmas, we have gathered a valuable portfolio of technologies and products supported by a strong IP strategy. We are a small and dynamic team, backed by solid partners. Our shareholders have invested more than $10 million to support our expansion. We are privileged to count two of the top animal health companies in the world as our distributors and beyond our partners, we reach a vast network of scientific and business resources in the Americas, Europe and Asia. 2 0 0 1 2005 2006 2007 2008 Technology transfer Coliprotec® sold in Canada Certification in Canada Prevtec do Brazil2009 2010 JOINING FORCES TO HELP FEEDTHEWORLD
• 7.
  Our network Milestones R&D Production Distribution Finance Elanco asdistributor Certification in Europe New products on the market Certification in Brazil Virbac as distributor Sales in new markets 2011 2012 2013 2014 2015 2016 2017 GROUPE GESTIONJAFACO GESTION ET FINANCEMENT DE P.M.E. INC.
• 8.
  Prevtec microbia Inc. HeadOffice 1250 René-Lévesque Blvd. West, 38th Floor Montréal, Canada +1 (514) 905-0401 Prevtec microbia Inc. R&D and Operations Center St-Hyacinthe, Canada +1 (450) 774-7000 Prevtec Microbia do Brazil Ltda Toledo, Brazil +55 (41) 8828 5610 Prevtec Microbia GmbH Munich, Germany +49-89-580 082 444 Barcelona, Spain +34 935 543 040 Prevtec Microbia HK Limited Hong Kong +862 5646 8551 Prevtec in Mainland China Beijing, China +86 147 1433 8551 © Prevtec microbia 2014 (141009)